Pfizer Inc (PFE)

$25.27 -0.21 (-0.82%)
Market Cap 144.87B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 7.96
Forward PE 8.53
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 50,256,300
Avg Vol 68,142,367
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 37%
Beta 0.47
Analysts Sell
Price Target $27.95

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
reyofhope
reyofhope Jan. 13 at 4:30 AM
$PFE my 50 k is parked here any solid news on the healthcare sector this moons.
1 · Reply
bioprof2
bioprof2 Jan. 13 at 4:16 AM
$CRDF that clinical trial record update impacts use of Ignite sites - opens it to other parties besides $PFE in a p3, would seem the m&a dance has begun, buckle up.
0 · Reply
Sambong
Sambong Jan. 13 at 4:11 AM
$PFE quarterly chart. its oversold at the current level. could be a 2nd buying opportunity.. just a share. not my cupnod tea.
0 · Reply
DragonAlgo
DragonAlgo Jan. 13 at 3:45 AM
🐉 $PFE PUT — DragonAlgo® Signal Contract: PFE PUT Expiry: 2026-01-16 | Strike: $25.50 | Type: PUT Option Plan (premium): Entry: $0.34 Stop: $0.25 TP1: $0.45 TP2: $0.59 TP3: $0.83 🔗 https://dragonalgo.com
0 · Reply
Abemeister
Abemeister Jan. 13 at 1:19 AM
$LLY $NVO $PFE exciting :-D
0 · Reply
Abemeister
Abemeister Jan. 13 at 12:10 AM
$NVO obesity drugs!!!!!! Let’s go! $LLY ty $PFE
0 · Reply
foghornL
foghornL Jan. 12 at 11:40 PM
$PFE $MRNA scary
1 · Reply
HFlier
HFlier Jan. 12 at 10:15 PM
$PFE This stock is only good for two things, eating option premiums and paying dividends. It will never change until they bring in a new CEO that takes the investment community to task.
0 · Reply
Willieberich
Willieberich Jan. 12 at 10:04 PM
$PFE going to pull 3000 shares out of here on the 26th move them to kraft stock. For another 7% dividend coming in the beginning of February .buy back here after its locked in on kraft ...good luck people..
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Jan. 12 at 9:58 PM
Enter: $PFE Calls Strike Price: $26 Expiry Date: FEB 06 2026 Buy in Price: $0.36 - $0.37 Sell Price: $0.68 Profit : +88% (Turn every $1 into $1.88) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
Latest News on PFE
Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra

Jan 12, 2026, 6:43 PM EST - 5 hours ago

Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra

Pfizer Inc. (PFE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 3:16 PM EST - 8 hours ago

Pfizer Inc. (PFE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

Jan 10, 2026, 10:00 AM EST - 2 days ago

Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

Healthy Returns: What to expect from pharma at the JPM conference

Jan 9, 2026, 12:57 PM EST - 3 days ago

Healthy Returns: What to expect from pharma at the JPM conference

AMGN AZN BMY LLY MRK NVO

Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity

Jan 8, 2026, 8:00 AM EST - 4 days ago

Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity

Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio

Jan 7, 2026, 2:16 PM EST - 5 days ago

Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio

Quant Q&A With Steven Cress

Jan 7, 2026, 7:00 AM EST - 5 days ago

Quant Q&A With Steven Cress

CLS CRDO ET FIX MRK

America's new vaccine doctrine for children replaces data with dogma

Jan 6, 2026, 11:55 AM EST - 6 days ago

America's new vaccine doctrine for children replaces data with dogma

MRNA

Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens

Jan 6, 2026, 7:30 AM EST - 6 days ago

Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Jan 5, 2026, 10:00 AM EST - 7 days ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer 2026: The Reset Year

Jan 2, 2026, 2:52 PM EST - 10 days ago

Pfizer 2026: The Reset Year

3 ultra-high-yield stocks to consider for $300 of dividend income in 2026

Dec 31, 2025, 8:37 AM EST - 12 days ago

3 ultra-high-yield stocks to consider for $300 of dividend income in 2026

AGNC PFLT

Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump

Dec 31, 2025, 6:08 AM EST - 12 days ago

Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump

GSK LLY NVS SNY

Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In January

Dec 26, 2025, 10:35 PM EST - 17 days ago

Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In January

CVX KMB ABM ABT AMGN AVGO BCPC

Pfizer says patient dies after receiving hemophilia drug in trial

Dec 23, 2025, 11:24 AM EST - 20 days ago

Pfizer says patient dies after receiving hemophilia drug in trial

Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound

Dec 19, 2025, 11:45 AM EST - 24 days ago

Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound

Trump to announce new drug-pricing deals later today

Dec 19, 2025, 10:45 AM EST - 24 days ago

Trump to announce new drug-pricing deals later today

ABBV AMGN AZN BMY GILD LLY MRK

Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts

Dec 18, 2025, 10:00 AM EST - 25 days ago

Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts

Pfizer Plays Catchup In Obesity Market, Licenses Weight-loss Drug From Fosun

Dec 18, 2025, 6:58 AM EST - 25 days ago

Pfizer Plays Catchup In Obesity Market, Licenses Weight-loss Drug From Fosun

AbbVie, several other pharma companies near MFN deal with Trump, sources say

Dec 17, 2025, 4:11 PM EST - 26 days ago

AbbVie, several other pharma companies near MFN deal with Trump, sources say

ABBV AMGN AZN BMY LLY NVS

Pfizer Stock Can Sink More. Here Is How

Dec 17, 2025, 2:36 PM EST - 26 days ago

Pfizer Stock Can Sink More. Here Is How

Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling Back

Dec 17, 2025, 10:14 AM EST - 26 days ago

Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling Back

MRK

PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Dec 17, 2025, 6:45 AM EST - 26 days ago

PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

Dec 16, 2025, 2:39 PM EST - 27 days ago

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

Pfizer falls on disappointing guidance

Dec 16, 2025, 12:33 PM EST - 27 days ago

Pfizer falls on disappointing guidance

Pfizer's modest 2026 outlook shows its big investments will take time to pay off

Dec 16, 2025, 10:12 AM EST - 27 days ago

Pfizer's modest 2026 outlook shows its big investments will take time to pay off

Here's why Pfizer is revising its revenue forecasts

Dec 16, 2025, 7:47 AM EST - 27 days ago

Here's why Pfizer is revising its revenue forecasts

Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales.

Dec 16, 2025, 7:25 AM EST - 27 days ago

Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales.

Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings

Dec 16, 2025, 7:16 AM EST - 27 days ago

Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings

Pfizer forecasts 2026 profit below expectations on lower COVID product sales

Dec 16, 2025, 6:54 AM EST - 27 days ago

Pfizer forecasts 2026 profit below expectations on lower COVID product sales

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

Dec 16, 2025, 6:45 AM EST - 27 days ago

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million

Dec 15, 2025, 8:24 AM EST - 4 weeks ago

Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million

ADPT

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

Dec 15, 2025, 8:00 AM EST - 4 weeks ago

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

ADPT

Pfizer Declares First-Quarter 2026 Dividend

Dec 12, 2025, 12:00 PM EST - 4 weeks ago

Pfizer Declares First-Quarter 2026 Dividend

Dividend Harvesting Portfolio Week 249: $24,900 Allocated, $2,646.53 In Projected Dividends

Dec 12, 2025, 8:45 AM EST - 4 weeks ago

Dividend Harvesting Portfolio Week 249: $24,900 Allocated, $2,646.53 In Projected Dividends

AMLP MO MSTY OHI

Health Rounds: Pfizer drug delays progression of advanced breast cancer in trial

Dec 12, 2025, 7:24 AM EST - 4 weeks ago

Health Rounds: Pfizer drug delays progression of advanced breast cancer in trial

Pfizer to cut hundreds of jobs in Switzerland to reduce costs, Bloomberg News reports

Dec 10, 2025, 11:38 AM EST - 4 weeks ago

Pfizer to cut hundreds of jobs in Switzerland to reduce costs, Bloomberg News reports

TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer

Dec 10, 2025, 8:15 AM EST - 4 weeks ago

TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer

Will Pfizer's YaoPharma deal deliver a powerful new oral obesity pill?

Dec 9, 2025, 3:30 PM EST - 4 weeks ago

Will Pfizer's YaoPharma deal deliver a powerful new oral obesity pill?

Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill

Dec 9, 2025, 11:14 AM EST - 4 weeks ago

Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill

Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons

Dec 9, 2025, 10:59 AM EST - 4 weeks ago

Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons

Pfizer: The Most Powerful Drug Pipeline In Pharma Could Deliver Major Long-Term Gains

Dec 9, 2025, 10:45 AM EST - 4 weeks ago

Pfizer: The Most Powerful Drug Pipeline In Pharma Could Deliver Major Long-Term Gains

Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500

Dec 9, 2025, 10:15 AM EST - 4 weeks ago

Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500

AES AMCR ARE CAG CPB D DOC

Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement

Dec 9, 2025, 6:55 AM EST - 4 weeks ago

Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement

Pfizer partners with YaoPharma for weight management treatment

Dec 9, 2025, 6:38 AM EST - 4 weeks ago

Pfizer partners with YaoPharma for weight management treatment

Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma

Dec 9, 2025, 6:30 AM EST - 4 weeks ago

Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma

HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors

Dec 6, 2025, 5:15 PM EST - 5 weeks ago

HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors

Pfizer: The Market Is Still Wrong About It

Dec 5, 2025, 9:00 AM EST - 5 weeks ago

Pfizer: The Market Is Still Wrong About It

17 dividend-stock bargains from a value manager with a stellar track record

Dec 2, 2025, 12:11 PM EST - 5 weeks ago

17 dividend-stock bargains from a value manager with a stellar track record

BMY CIVI CMCSA CVS MOS MRK MTH

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

Dec 1, 2025, 3:50 PM EST - 6 weeks ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX MRNA NVAX

reyofhope
reyofhope Jan. 13 at 4:30 AM
$PFE my 50 k is parked here any solid news on the healthcare sector this moons.
1 · Reply
bioprof2
bioprof2 Jan. 13 at 4:16 AM
$CRDF that clinical trial record update impacts use of Ignite sites - opens it to other parties besides $PFE in a p3, would seem the m&a dance has begun, buckle up.
0 · Reply
Sambong
Sambong Jan. 13 at 4:11 AM
$PFE quarterly chart. its oversold at the current level. could be a 2nd buying opportunity.. just a share. not my cupnod tea.
0 · Reply
DragonAlgo
DragonAlgo Jan. 13 at 3:45 AM
🐉 $PFE PUT — DragonAlgo® Signal Contract: PFE PUT Expiry: 2026-01-16 | Strike: $25.50 | Type: PUT Option Plan (premium): Entry: $0.34 Stop: $0.25 TP1: $0.45 TP2: $0.59 TP3: $0.83 🔗 https://dragonalgo.com
0 · Reply
Abemeister
Abemeister Jan. 13 at 1:19 AM
$LLY $NVO $PFE exciting :-D
0 · Reply
Abemeister
Abemeister Jan. 13 at 12:10 AM
$NVO obesity drugs!!!!!! Let’s go! $LLY ty $PFE
0 · Reply
foghornL
foghornL Jan. 12 at 11:40 PM
$PFE $MRNA scary
1 · Reply
HFlier
HFlier Jan. 12 at 10:15 PM
$PFE This stock is only good for two things, eating option premiums and paying dividends. It will never change until they bring in a new CEO that takes the investment community to task.
0 · Reply
Willieberich
Willieberich Jan. 12 at 10:04 PM
$PFE going to pull 3000 shares out of here on the 26th move them to kraft stock. For another 7% dividend coming in the beginning of February .buy back here after its locked in on kraft ...good luck people..
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Jan. 12 at 9:58 PM
Enter: $PFE Calls Strike Price: $26 Expiry Date: FEB 06 2026 Buy in Price: $0.36 - $0.37 Sell Price: $0.68 Profit : +88% (Turn every $1 into $1.88) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
dloeb
dloeb Jan. 12 at 9:45 PM
$PFE continues to grate the hide of investors who buy so better be tough on the backside. Still thinking it gets back into the 22-23 range for support at some point before breaking out of this back and forth
1 · Reply
AFJuvat
AFJuvat Jan. 12 at 9:43 PM
$PFE Bourla needs to retire and hide in the deepest hole asap.
1 · Reply
StocktwitsNews
StocktwitsNews Jan. 12 at 9:22 PM
Pfizer CEO Eyes Big Push Towards Obesity Drug Development In 2026 After $10B Metsera Acquisition $PFE $VTI $VOO https://stocktwits.com/news/equity/markets/pfizer-ceo-eyes-big-push-towards-obesity-drug-development-in-2026/cmUafq6R4ED
0 · Reply
VeryBerryBusy
VeryBerryBusy Jan. 12 at 9:20 PM
$PFE Bourla needs to visit Mar a lago asap
0 · Reply
Twitter70
Twitter70 Jan. 12 at 9:02 PM
$PFE Profit taking 🤣
0 · Reply
QEInfinity
QEInfinity Jan. 12 at 8:54 PM
$PFE Picked up a little bit, I'm mostly looking for boring defensive things right now and this fit the bill in a sector I have little exposure to.
0 · Reply
Micheal_Pothead
Micheal_Pothead Jan. 12 at 8:40 PM
$PFE at this point I’m convinced that even replacing Albert wouldn’t make the stock go up
1 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jan. 12 at 8:33 PM
$PFE
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Jan. 12 at 8:30 PM
$PFE was thinking my CCCP stock (BABA) was riskier but nicely performing these days
0 · Reply
Micheal_Pothead
Micheal_Pothead Jan. 12 at 8:20 PM
$PFE it’s truly incredible how any news at all for this stock is bad news
1 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Jan. 12 at 8:15 PM
$PFE i reckon the engulfing bearish daily chart will say it all as any attempts to stabilize or reverse receives more selling. Something in the cooker and soon to be landing in our laps I would bet
0 · Reply
A_Train1
A_Train1 Jan. 12 at 8:12 PM
$PFE so, safe to say that the weekend news about the phase 3 had no impact?
1 · Reply